Church & Dwight’s focused power-brand portfolio and 5.8% organic growth support compounding, but a 32.2x P/E leaves limited near-term valuation cushion.
Church & Dwight Co Inc is a premier developer, manufacturer, and distributor of household and personal care products, operating as a resilient competitor in the global consumer packaged goods sector [cite: 1, 2]. The company's strategic blueprint concentrates capital, supply chain resources, and advertising support behind a highly focused group of "power brands" [cite: 2, 3]. By leveraging brand equity and product adjacency innovations, the company maintains dominant positions across highly predictable, repeat-purchase categories [cite: 2].
The company generates its revenue across three principal segments: Consumer Domestic, Consumer International, and the Specialty Products Division (SPD) [cite: 4]. Consumer Domestic represents the largest engine of growth, offering a balance of household utility products such as laundry detergents and cat litters, alongside high-growth personal care items like oral care products, acne treatments, and sexual wellness goods [cite: 2, 4]. Consumer International replicates this consumer-facing portfolio across major international subsidiaries, while the Specialty Products Division serves industrial, food, and animal agriculture markets with bicarbonate-based products and performance chemicals [cite: 4, 5].
Geographically, the United States remains the primary end market, generating approximately 77% of consolidated net sales, while the international division represents 18% and the Specialty Products Division makes up the remaining 5% of global sales [cite: 6]. The company's primary customer base consists of mass merchandisers, grocery stores, wholesale clubs, and drug store chains, as well as a rapidly growing global e-commerce network which now commands a 25.5% share of total consumer sales [cite: 4, 7]. Walmart stands as the company's largest single customer, accounting for approximately 23% of consolidated sales [cite: 8].
| Operating Segment | % of Net Sales | Product Examples | End Markets Served |
|---|---|---|---|
| Consumer Domestic | ~77% [cite: 6] | Liquid Detergent, Cat Litter, Acne Patches [cite: 4, 9] | U.S. Retail Consumers [cite: 2, 4] |
| Consumer International | ~18% [cite: 6] | Dry Shampoo, Mouthwash, Acne Care [cite: 9] | Global Retail Consumers [cite: 4, 10] |
| Specialty Products Division | ~5% [cite: 6] | Sodium Bicarbonate, Animal Feed [cite: 2, 5] | B2B Agricultural & Industrial [cite: 2, 5] |
The core customer value proposition of Church & Dwight lies in its balanced premium-to-value portfolio [cite: 6]. Approximately 64% of the portfolio is categorized as premium, while 36% targets the value segment [cite: 6]. This dual exposure acts as a strong operational buffer, allowing the company to capture trade-down consumer behavior during periods of economic contraction while sustaining pricing power during expansionary cycles [cite: 6].
Consumers and retail partners choose Church & Dwight over competitors because its products provide clinical efficacy and cost-effective household solutions [cite: 2, 4]. Furthermore, the company has restricted its portfolio exposure to private label alternatives to a modest 12% across its key operating categories [cite: 6]. This keeps its products top-of-mind, ensures strong brand loyalty, and protects its retail shelf allocation [cite: 4, 6].
The growth model of Church & Dwight is driven by standard category innovations, selective high-margin bolt-on acquisitions, and international distribution expansion [cite: 2, 4]. The company sells everyday problem-solving goods [cite: 2]. Within the Consumer Domestic Household segment, core revenue is driven by Arm & Hammer liquid laundry detergent, Arm & Hammer cat litter, and OxiClean stain fighters [cite: 4, 9]. The Personal Care segment is anchored by TheraBreath oral rinses and toothpastes, Hero Cosmetics acne patches, Trojan sexual wellness products, Batiste dry shampoos, Nair depilatories, Nair reproductive diagnostics, and Zicam over-the-counter remedies [cite: 1, 2, 9]. Recent acquisitions, such as Touchland hand sanitizer and Miss Mouth's Messy Eater stain remover, are driving double-digit sales growth, helping to transition the portfolio toward higher-velocity consumer brands [cite: 11, 12, 13].
The strategic pivot executed in 2025 involved exiting slower-moving, small appliance, and lower-margin segments—specifically the vitamin, Flawless beauty devices, Spinbrush, and Waterpik showerhead businesses [cite: 3, 12]. This portfolio transformation has significantly enhanced operational focus and resource allocation [cite: 13, 14]. The benefits of these actions are evident in consumption patterns: excluding the exited businesses, U.S. consumption grew by a robust 3.5% in 2025, compared to just 0.9% on a reported basis [cite: 12, 14]. This positioning aligns the company for stronger, less volatile organic growth moving forward [cite: 3, 12].
| Core Brand | Primary Segment | Competitive Position & Core Focus |
|---|---|---|
| Arm & Hammer | Household / Personal Care | Flagship brand; driving expansion from $2B to $3B in sales [cite: 3, 4] |
| TheraBreath | Personal Care (Oral Care) | High-growth premium oral rinse; expanding share to 25.3% [cite: 3, 15] |
| Hero Cosmetics | Personal Care (Acne Care) | Acne care leader; expanding into cleansers and liquid patches [cite: 3, 7] |
| Touchland | Personal Care (Sanitation) | Digitally native premium hand sanitizer; scaling internationally [cite: 14, 16] |
| Trojan | Personal Care (Wellness) | Market-leading brand; driving growth via the new G.O.A.T. platform [cite: 2, 14] |
The economic moat protecting Church & Dwight's operating margins is constructed from valuable brand equity, robust physical distribution networks, and a unique manufacturing cost advantage [cite: 4]. While pure switching costs are low for consumer packaged goods, the high loyalty commanded by legacy brands like Arm & Hammer, Trojan, and Hero prevents major competitive displacement [cite: 2, 17].
The company's scale allows it to secure competitive retail shelf space and maintain strong digital visibility, which is critical given that e-commerce now represents 25.5% of total consumer sales [cite: 11]. Furthermore, in its Specialty Products Division, Church & Dwight operates as the largest domestic producer of sodium bicarbonate [cite: 5]. This creates a low-cost raw material supply for its consumer baking soda, laundry, and cat litter lines, establishing a structural cost advantage that smaller competitors cannot replicate [cite: 2, 5].
The Total Addressable Market (TAM) opportunity is extensive and supported by long-term management goals [cite: 2, 4]. Management plans to expand the Arm & Hammer brand from a $2 billion business to a $3 billion business by entering adjacent consumer categories [cite: 3, 4]. Additionally, the company aims to expand its global oral care division to $1.5 billion and grow its international segment from $1 billion to $2 billion through organic distribution gains and targeted bolt-on acquisitions in key markets such as Canada, Germany, the United Kingdom, France, Australia, and Mexico [cite: 4].
The competitive landscape consists of large consumer goods conglomerates with greater financial scale [cite: 4]. Church & Dwight competes directly with Procter & Gamble in laundry and oral care, Colgate-Palmolive in oral care, Clorox in household cleaning, and Kimberly-Clark in personal hygiene [cite: 4, 18, 19]. Despite this intense competition, Church & Dwight continues to hold and gain ground [cite: 12, 20].
Its premium brands are outperforming their respective categories; TheraBreath mouthwash reached a 25.3% market share in recent quarters, representing a 4.5 percentage point increase [cite: 15]. Additionally, cat litter consumption grew by 7.5%, and the Miss Mouth's acquisition grew over 50% [cite: 15]. In highly promotional categories like laundry, the company maintains its market position through targeted trade spending and productivity programs [cite: 15, 17].
Church & Dwight announced its second-quarter 2026 financial results on July 30, 2026, delivering performance that exceeded top-line expectations [cite: 21, 22]. Net sales reached $1,530.0 million, representing a year-over-year reported increase of 1.6% and beating consensus estimates of $1.50 billion by approximately 2% [cite: 15, 21]. Organic sales growth was strong at 5.8%, outperforming the company's guidance of 3% [cite: 15, 23]. Growth was driven by a volume increase of 4.3% and positive price/product mix of 1.5% [cite: 11, 24].
Diluted reported EPS stood at $0.85, up 9.0% year-over-year [cite: 21]. Adjusted EPS was $0.89, matching the consensus analyst forecast of $0.89 and exceeding the company's internal quarterly outlook of $0.88 [cite: 7, 23]. In comparison, Adjusted EPS was $0.94 in the prior year's second quarter, with the decline reflecting higher marketing expenditures and Touchland-related SG&A expenses [cite: 9, 21].
| Financial Metric | Q2 2026 | Q2 2025 | Reported Change | Organic Change |
|---|---|---|---|---|
| Net Sales | $1,530.0 Million [cite: 21] | $1,506.3 Million [cite: 21] | +1.6% [cite: 21] | +5.8% [cite: 21] |
| Gross Margin | 45.4% [cite: 21] | 43.0% [cite: 21] | +240 bps [cite: 21] | — |
| Adjusted Gross Margin | 45.4% [cite: 21] | 45.0% [cite: 21] | +40 bps [cite: 21] | — |
| Reported Diluted EPS | $0.85 [cite: 21] | $0.78 [cite: 21] | +9.0% [cite: 21] | — |
| Adjusted Diluted EPS | $0.89 [cite: 21] | $0.94 [cite: 21] | -5.3% [cite: 21] | — |
| Operating Cash Flow | $286.8 Million [cite: 21] | — | +24.3% [cite: 21] | — |
Gross margin increased 240 basis points to 45.4% on a reported basis, while adjusted gross margin expanded 40 basis points to 45.4% [cite: 21]. This expansion was driven by volume leverage, productivity programs, and favorable product mix, which offset inflation and transportation cost increases [cite: 9, 21].
However, adjusted operating income fell by approximately 9.1% to $287.2 million [cite: 21]. This margin compression was driven by a 220 basis point increase in Adjusted SG&A (to 15.8% of sales), reflecting operating costs and amortization from the Touchland hand sanitizer acquisition, alongside a 40 basis point increase in marketing expenses to 10.8% of net sales to support new product launches [cite: 9, 21]. Year-to-date operating cash flow was strong at $461.6 million, up 10.8% year-over-year [cite: 9, 21].
Following first-half outperformance, management raised its full-year 2026 guidance [cite: 21]. Net sales growth is now projected to be flat to +1.0% (previously a decline of -1.5% to -0.5%) [cite: 21]. Organic sales growth is expected to reach 4.0% to 5.0% (up from 3.0% to 4.0%) [cite: 21].
Adjusted EPS growth guidance was raised to a range of 6.0% to 8.0% (previously 5.0% to 8.0%), with reported EPS projected to increase 20% to 22% [cite: 7, 21]. Additionally, full-year operating cash flow guidance was raised to approximately $1.175 billion [cite: 21]. Full-year capital expenditures are expected to remain flat at $130 million, or approximately 2% of sales, reflecting a normalized spending level [cite: 7, 25].
During the earnings call, management highlighted that new product launches are expected to account for approximately half of organic sales growth in 2026 [cite: 7]. They highlighted key product launches, including TheraBreath Complete Revitalizing Mint rinse, Arm & Hammer cat litter with Microban product protection, and Hero facial cleansers and Mighty Shield liquid acne patches [cite: 7].
Management noted approximately $30 million in transitory cost headwinds from raw materials and oil-based transportation surcharges, which they expect to mitigate through productivity programs [cite: 23]. They also highlighted a $15 million phase-two tariff refund expected in the second half of 2026 [cite: 23]. This benefit will be reinvested into brand-building and consumer-facing activities [cite: 26].
The market reacted positively to the Q2 results, with the stock price rising 3.8% on the day of the release, driven by the raised full-year outlook [cite: 27]. Following the report, several sell-side analysts updated their recommendations and raised their 12-month price targets [cite: 27]. This pushed the average consensus price target to $105.37 from $102.16 [cite: 28].
| Valuation Metric | August 2026 Value | Historical 10-Year Average | Peer Group Median |
|---|---|---|---|
| Trailing P/E Ratio | 32.2x [cite: 29] | 31.2x [cite: 18] | 17.1x [cite: 29] |
| Forward P/E Ratio | 32.9x [cite: 18, 29] | — | — |
| EV / EBITDA | 18.9x [cite: 19] | 19.8x [cite: 19] | 8.1x [cite: 19] |
| EV / Revenue | 4.2x [cite: 29] | — | — |
The trailing P/E multiple of 32.2x reflects a standard premium compared to both the historical ten-year average and the peer group median [cite: 18, 29]. This valuation premium is fundamentally linked to the durability of the company's core business model [cite: 2]. Church & Dwight has maintained a stable five-year sales growth CAGR of 4.8% and a ten-year sales growth CAGR of 6.2% [cite: 30].
The company's low cash flow volatility, combined with its strong return on invested capital and minimal capital expenditure requirements, supports its valuation premium [cite: 3]. Its balanced product portfolio—divided between premium and value brands—helps insulate financial performance from broader consumer staples volatility [cite: 2, 6].
Evaluating Church & Dwight's operational structure reveals several execution, competitive, and macroeconomic risks [cite: 3, 4]. On a company-specific level, execution risk is primarily centered on the integration of premium acquisitions like Touchland and Miss Mouth's Messy Eater, which represent a cumulative investment of over $1 billion [cite: 1, 11, 26]. If these high-growth brands fail to sustain their momentum as they transition into physical retail channels, the company could face intangible asset write-downs similar to those experienced in its vitamins business [cite: 12].
Additionally, the company is managing a multi-year enterprise resource planning (ERP) upgrade project [cite: 20]. This project is expected to create temporary cost headwinds, representing a 1% impact on 2026 adjusted EPS growth [cite: 20]. This initiative creates potential operational disruption risks during the transition phase [cite: 20].
Competitive and industry structure risks are driven by retail channel dynamics and pricing pressure [cite: 4]. The rise of private labels and retailer co-developed brands poses a constant threat to the company's market share [cite: 4]. In highly promotional categories like domestic laundry, price wars with larger competitors could force the company to increase trade spending, compressing operating margins [cite: 4, 15].
This threat is amplified by distribution concentration [cite: 4]. Since Walmart accounts for approximately 23% of consolidated sales, the company is exposed to customer concentration risk [cite: 8]. Any changes in Walmart's inventory policies, pricing demands, or shelf allocations could impact the company's top-line performance [cite: 4, 31].
Regulatory, legal, and macroeconomic sensitivities are linked to trade policy and commodity price volatility [cite: 3, 4]. The company has paid approximately $23.0 million in tariffs under the International Emergency Economic Powers Act [cite: 26]. While it expects a $15 million refund in the second half of 2026, future changes in trade policies could create additional supply-chain pressures [cite: 23, 26].
On the commodity front, the company is highly sensitive to fluctuations in petroleum-based raw materials, surfactants, and packaging resins [cite: 3, 4]. Management noted that crude oil pricing around $90 per barrel contributes to approximately $30 million in transitory transportation and manufacturing cost headwinds [cite: 23]. On the balance sheet, capital allocation risk is currently mitigated by a low leverage level of approximately 1.7x [cite: 3]. However, a large-scale, transformative acquisition could raise debt levels and complicate the company's financial profile [cite: 3].
[Commodity Resin & Oil Cost Spikes] ---> [Adjusted Gross Margin Compression]
|
v
[Walmart Inventory/Pricing Demands] ---> [Operating Margin Underperformance]
|
v
[Premium Acquired Brand Growth Slowdown] ---> [Intangible Asset Impairment Risk]
To help investors monitor these risks, the following analytical framework distinguishes between near-term setbacks, early warning signs, and structural threats to the long-term investment thesis:
Evaluating the 5-year valuation trajectory of Church & Dwight through FY2031 requires assessing its revenue growth, profitability, share repurchases, and exit multiples [cite: 32]. Projections are constructed from a normalized FY2026 revenue baseline of $6,260 million, aligned with current guidance [cite: 21, 32].
The Base Case assumes the consumer staples sector normalizes, and Church & Dwight's strategic exits from low-velocity segments continue to focus resources on core consumables [cite: 3, 32]. Sales grow at a compound annual rate (CAGR) of 4.5% over the next five years, fueled by international distribution gains and category expansion within the Arm & Hammer and oral care lines [cite: 2, 4, 32]. Net profit margins improve to 13.0% (up from 11.9% in 2025), driven by productivity programs and the integration of high-margin Touchland and Miss Mouth's products [cite: 8, 21, 32].
Capital deployment remains disciplined, and consistent share repurchases reduce the diluted outstanding share count by 0.5% annually, leaving 240.0 million shares by Year 5 [cite: 3, 32]. Year 5 Net Income reaches $1,014.1 million, generating diluted EPS of $4.23 [cite: 32]. Applying a conservative exit P/E multiple of 28.0x (reflecting a mild contraction from the current premium multiple of 32.2x to align with historical sector averages), the implied share price in FY2031 is $118.32 [cite: 29, 32]. This outcome translates to a 5-year total return of 19.0% and an annualized return of 3.5% [cite: 32].
The Low Case scenario models a prolonged macroeconomic slowdown, persistent crude oil price inflation above $90 per barrel, and heightened promotional pricing wars in the laundry category [cite: 3, 23, 32]. Revenue growth slows to a 2.0% CAGR, resulting in Year 5 net sales of $6,911.5 million [cite: 32]. Net margins compress to 11.0% due to tariff pressures, commodity resin costs, and competitive price pressures [cite: 3, 4, 32].
Free cash flow generation is restricted, prompting management to suspend share buybacks to protect its investment-grade balance sheet, keeping the diluted share count flat at 246.0 million [cite: 3, 32]. Year 5 Net Income falls to $760.3 million, yielding an EPS of $3.09 [cite: 32]. Under valuation multiple contraction, the exit P/E ratio falls to 22.0x, resulting in an implied share price of $67.99 [cite: 32]. This represents a total return of -31.6% (annualized return of -7.3%) [cite: 32].
The High Case assumes that consumer confidence rebounds and high-margin acquisitions maintain their rapid growth, with Miss Mouth's Messy Eater sustaining a 50%+ growth trajectory [cite: 6, 15]. Arm & Hammer successfully expands into new categories, achieving its $3 billion target ahead of schedule [cite: 3, 4]. These factors drive a 6.5% five-year sales CAGR, with net sales reaching $8,576.7 million by FY2031 [cite: 32].
Net profit margins reach 14.5% due to scale-driven SG&A leverage and premium portfolio mix [cite: 21, 32]. Strong free cash flow allows management to repurchase shares at a 1.5% annual rate, reducing the share count to 228.0 million [cite: 32]. Year 5 Net Income rises to $1,243.6 million, generating an EPS of $5.45 [cite: 32]. Strong growth and premium positioning help defend a 32.0x exit P/E multiple, yielding an implied share price of $174.54 [cite: 18, 32]. This delivers a total return of 75.5% (annualized return of 11.9%) [cite: 32].
By assigning subjective probabilities of 50% to the Base Case, 20% to the Low Case, and 30% to the High Case, the probability-weighted expected share price for Church & Dwight in five years is calculated at $125.12 [cite: 32]. This expected valuation indicates a steady compounding profile with asymmetric upside potential, assuming execution remains strong [cite: 32].
$\text{Weighted Expected Value} = (\$118.32 \times 0.50) + (\$67.99 \times 0.20) + (\$174.54 \times 0.30) = \$125.12$
To help visualize the trajectory from the current share price of $99.43, the following table models the projected share price pathway across each of the three scenarios:
| Year | Year 0 (Current) | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 (FY2031) |
|---|---|---|---|---|---|---|
| Base Case (USD) | $99.43 [cite: 33] | $102.91 | $106.51 | $110.24 | $114.37 | $118.32 [cite: 32] |
| Low Case (USD) | $99.43 [cite: 33] | $92.10 | $85.31 | $79.02 | $73.18 | $67.99 [cite: 32] |
| High Case (USD) | $99.43 [cite: 33] | $111.36 | $124.72 | $139.69 | $156.45 | $174.54 [cite: 32] |
The following matrix summarizes the key operating and valuation metrics driving the three five-year scenarios through FY2031:
| Scenario | Year 5 Revenue ($M) | Year 5 Net Margin % | Year 5 Share Count (M) | Exit P/E Multiple | Current Share Price ($) | Implied Year 5 Price ($) | 5-Year Total Return | Annualized Return | Subjective Probability |
|---|---|---|---|---|---|---|---|---|---|
| Base Case | $7,801.1 [cite: 32] | 13.0% [cite: 32] | 240.0 [cite: 32] | 28.0x [cite: 32] | $99.43 [cite: 33] | $118.32 [cite: 32] | +19.0% [cite: 32] | +3.5% [cite: 32] | 50% [cite: 32] |
| Low Case | $6,911.5 [cite: 32] | 11.0% [cite: 32] | 246.0 [cite: 32] | 22.0x [cite: 32] | $99.43 [cite: 33] | $67.99 [cite: 32] | -31.6% [cite: 32] | -7.3% [cite: 32] | 20% [cite: 32] |
| High Case | $8,576.7 [cite: 32] | 14.5% [cite: 32] | 228.0 [cite: 32] | 32.0x [cite: 32] | $99.43 [cite: 33] | $174.54 [cite: 32] | +75.5% [cite: 32] | +11.9% [cite: 32] | 30% [cite: 32] |
ASYMMETRIC RISK PROFILE
The leadership team's interests are closely aligned with shareholders through stock ownership requirements [cite: 34]. The Chief Executive Officer must hold shares equivalent to 6.0 times base salary, the Chief Financial Officer must hold 3.0 times, and other senior executives must hold 2.5 times [cite: 34, 35]. Additionally, executive compensation target annual bonuses (such as CFO Lee McChesney's 85% base bonus structure) are directly tied to financial metrics like net sales, adjusted gross margin, and operating income [cite: 34, 36]. Non-employee directors also participate in phantom stock plans settled in cash, reinforcing long-term equity tracking and alignment with outside shareholders [cite: 37].
Revenue quality is structurally strong, as over 85% of revenue is derived from repeat-purchase consumer staples with stable consumption patterns [cite: 2]. The company's brand strength, particularly under the Arm & Hammer and personal care franchises, provides reliable customer retention [cite: 2, 14]. Furthermore, the company has restricted its portfolio exposure to private label alternatives to a modest 12% across its key operating categories, protecting its pricing power and retail shelf space [cite: 6].
The company continues to hold and gain ground across its key categories, as evidenced by a 4.5 percentage point market share expansion in TheraBreath mouthwash (reaching 25.3% share) and a 7.5% increase in cat litter consumption [cite: 15]. In highly promotional categories like laundry, the company maintains its market position through targeted trade spending and productivity programs [cite: 15, 17].
The rescaled portfolio focused on core consumables provides a solid foundation, and standard new product innovation accounts for approximately half of annual organic growth [cite: 7, 13]. International expansion through the Global Markets Group offers selective runway, though domestic categories remain relatively mature [cite: 4, 7].
The balance sheet remains in excellent health, with a leverage profile of 1.7x net debt to EBITDA [cite: 3]. Capital expenditures are highly optimized at 2.0% of annual sales, driving robust and consistent free cash flow generation [cite: 3, 7]. S&P maintains a positive outlook on its BBB+ investment-grade credit rating [cite: 3].
The long-term durability of the brand portfolio is high, supported by the clinical efficacy of products like TheraBreath and Hero [cite: 2, 12]. However, the company faces potential choke points, particularly standard consumer staples headwinds (freight, oil costs) and high retail concentration with Walmart representing 23% of consolidated sales [cite: 3, 8].
Management has executed a highly disciplined capital allocation strategy, delivering its 502nd consecutive regular dividend and 30 consecutive years of dividend increases [cite: 11, 14]. The company balance sheet exhibits disciplined financing, alternating between gross share repurchases and opportunistic M&A [cite: 3].
While sell-side consensus remains a Hold due to multiple expansion and valuation [cite: 38, 39], institutional buy-side interest is strong [cite: 27]. Large positions have been initiated or added to by Legal & General, the Canada Pension Plan, and Assenagon Asset Management [cite: 27, 38].
Adjusted gross margins are healthy and expanding at 45.4% [cite: 21]. However, near-term operating margin flow-through has been constrained by increased brand-support marketing investments (exceeding 11% of sales) and high Touchland-related SG&A expenses [cite: 21, 40].
The company has delivered exceptional shareholder returns over the long term, driven by the successful execution of its "Evergreen" business model [cite: 41]. Despite past segment impairments, the long-term compounding of sales, gross profit, and cash flow has consistently created shareholder value [cite: 30, 42].
The following table summarizes the qualitative scores assigned to each category, representing a balanced operational overview:
| Scorecard Dimension | Score (1-10) | Core Qualitative Underpinning |
|---|---|---|
| Management Alignment | 9 / 10 | CEO required to hold 6x base salary; bonuses tied to core targets [cite: 34, 35]. |
| Revenue Quality | 9 / 10 | Essential consumables with limited private-label exposure of 12% [cite: 2, 6]. |
| Market Position | 8 / 10 | Gaining share in oral care and acne care; holding laundry position [cite: 15]. |
| Growth Outlook | 8 / 10 | rescaled portfolio focused on consumables; standard new product runway [cite: 7, 13]. |
| Financial Health | 9 / 10 | Positive S&P outlook on BBB+ rating; low debt leverage at 1.7x [cite: 3]. |
| Business Viability | 8 / 10 | Long-term durability is high, but Walmart reliance remains at 23% [cite: 2, 8]. |
| Capital Allocation | 9 / 10 | 30 consecutive years of dividend increases; opportunistic share buybacks [cite: 3, 14]. |
| Analyst Sentiment | 7 / 10 | Consensus Hold due to multiple expansion; average target at $105.37 [cite: 29, 39]. |
| Profitability | 8 / 10 | Healthy adjusted gross margin at 45.4%; near-term SG&A inflation [cite: 21]. |
| Track Record | 9 / 10 | Consistent value creation and execution of the "Evergreen" model [cite: 41]. |
| Blended Qualitative Score | 8.4 / 10 | Highly resilient business with disciplined financial execution [cite: 3]. |
HIGH QUALITY COMPOUNDER
Church & Dwight represents a resilient consumer staples business that has successfully reshaped its product portfolio to prioritize high-margin, high-velocity consumables while divesting slower-moving non-core divisions [cite: 3, 13]. The company's second-quarter 2026 results confirm this strategy is working, delivering 5.8% organic sales growth and robust volume-driven expansion that exceeded prior management expectations [cite: 21]. The domestic and international consumer segments continue to gain market share, supported by innovative product rollouts and strong execution within the TheraBreath, Hero, and Touchland franchises [cite: 9, 15].
Although elevated crude oil pricing and logistic surcharges create short-term cost headwinds, productivity programs and expected tariff refunds provide operational flexibility to fund brand-support marketing investments [cite: 23, 26]. The long-term investment thesis is anchored on the company's defensive pricing power, low capital expenditure requirements, and exceptional cash flow generation [cite: 3, 7, 43].
With leverage at 1.7x and a positive rating outlook from S&P, the balance sheet provides strategic optionality to pursue selective bolt-on acquisitions and execute share buybacks [cite: 3, 4]. While the trailing P/E multiple of 32.2x indicates that the market is already pricing in much of this operational stability, the company's low private-label exposure and balanced premium-value positioning should help protect financial performance [cite: 6, 29]. Key catalysts to monitor over the next twelve months include international distribution gains, the pace of ERP integration, and gross margin progression [cite: 4, 7, 20].
DEFENSIVE CASH MACHINE
Church & Dwight's share price continues to trade in a stable bullish trend, anchored above its 200-day simple moving average of $94.70 and its 200-day exponential moving average of $99.82 [cite: 33, 44]. The stock has established a consolidation range between key support at $93.34 and resistance at $102.74, making it highly resilient to broader market volatility [cite: 45].
Daily technical indicators exhibit a positive momentum bias, with the Relative Strength Index (RSI) at a neutral-to-bullish 65.8 and a positive MACD of 0.80, suggesting continued accumulation by institutional buyers [cite: 44]. In the short term, the stock is expected to remain range-bound within its established defensive corridor as the market digests macroeconomic yield changes and geopolitical energy pressures [cite: 38].
STABLE BULLISH CONSOLIDATION
View Church & Dwight Co., Inc. (CHD) stock page
Loading the interactive version of this report…